Andrew Ko
MD
Professor of Clinical Medicine
👥Biography 个人简介
Dr. Andrew Ko is a leading clinical investigator in pancreatic cancer who has conducted major trials examining MEK inhibitors, novel combination regimens, and FOLFIRINOX-based approaches. He has been deeply involved in multi-institutional PDAC trial consortia and is known for his work on biomarker-driven strategies in pancreatic cancer. He has contributed substantially to defining systemic therapy approaches for borderline resectable disease.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Andrew Ko 的研究动态
Follow Andrew Ko's research updates
留下邮箱，当我们发布与 Andrew Ko（UCSF Helen Diller Family Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment